Internal Medicine, Hematology & Oncology · Hagerstown, MD
NPI
1093913527
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1185 Imperial Dr Ste 103
Hagerstown, MD, 21740
Phone (301) 797-8279
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.8M
330,728 services
Medicare patients, 2024
685
Average age 74
Drug cost, 2024
$4.7M
1,702 prescriptions
Company payments, 2025
$3,897
From 53 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yong Tang was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 49,470 times for 35 patients. In total Yong Tang billed 330,728 services in 109 codes, and Medicare paid $4.8M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-16.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 49,470 | 35 | $0.27 | $13K |
| J0897 Injection, denosumab, 1 mg | Office | 10,980 | 26 | $20.38 | $224K |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 7,320 | 19 | $5.73 | $42K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 2,817 | 48 | $0.23 | $658 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 2,230 | 23 | $0.25 | $557 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,960 | 28 | $0.09 | $177 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,430 | 20 | $0.68 | $975 |
| 96375 Injection Administration | Office | 1,196 | 76 | $12.98 | $16K |
| 99213 Office E&M - Established | Office | 1,054 | 542 | $68.78 | $72K |
| 96413 Chemotherapy Administration | Office | 571 | 65 | $108.12 | $62K |
| 96372 Injection Administration | Office | 521 | 63 | $11.77 | $6,133 |
| 99214 Office E&M - Established | Office | 515 | 218 | $102.11 | $53K |
| 96415 Chemotherapy Administration | Office | 441 | 43 | $23.42 | $10K |
| 96401 Chemotherapy Administration | Office | 362 | 41 | $58.71 | $21K |
| 96366 Intravenous Infusion, Hydration | Office | 331 | 17 | $17.38 | $5,753 |
By year: 2022 $4.6M for 259,959 services; 2023 $4.5M for 257,818 services; 2024 $4.8M for 330,728 services.
Medicare prescription drug claims, 2024
In 2024, the drug Yong Tang prescribed most often to Medicare patients was Eliquis (Apixaban), with 153 prescriptions and refills. In total Yong Tang wrote 1,702 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 153 | 263 | 40 | $149K |
| Letrozole Generic | 97 | 248 | 28 | $2,682 |
| Acyclovir Generic | 73 | 143 | 22 | $1,332 |
| Prednisone Generic | 58 | 84 | 22 | $373 |
| Imbruvica Ibrutinib | 46 | 46 | Under 11 | $525K |
| Revlimid Lenalidomide | 46 | 46 | Under 11 | $811K |
| Warfarin Sodium Generic | 46 | 114 | 13 | $690 |
| Xarelto Rivaroxaban | 45 | 102 | 14 | $55K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 45 | 45 | Under 11 | $971 |
| Ondansetron Hcl Generic | 42 | 44 | 21 | $506 |
| Prochlorperazine Maleate Generic | 40 | 42 | 21 | $824 |
| Oxycodone Hcl Generic | 38 | 38 | Under 11 | $492 |
| Reblozyl Luspatercept-Aamt | 37 | 37 | Under 11 | $513K |
| Tramadol Hcl Generic | 37 | 37 | 16 | $236 |
| Imatinib Mesylate Generic | 34 | 34 | Under 11 | $5,077 |
Brand drugs: - claims; generic drugs: 1,165 claims; opioid claims: 189.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yong Tang $3,897 ($3,897 in general payments such as food, travel and fees) from 53 companies. The largest payer was Janssen Biotech, Inc. with $318.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 15 | $318 |
| Incyte Corporation INCY | 8 | $198 |
| TerSera Therapeutics LLC | 8 | $192 |
| Gilead Sciences, Inc. GILD | 3 | $177 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $176 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $143 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $139 |
| Merck Sharp & Dohme LLC MRK | 5 | $130 |
| PharmaEssentia USA Corporation 6446.TW | 4 | $129 |
| Pfizer Inc. PFE | 6 | $127 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.